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Volume 57, Number 5S Abstracts 83Selevations of serum creatinine occur days later and research
into makers of early kidney injury has focused on various
proteins with disappointing results. Our animal data
revealed that even low dose contrast leads to kidney injury
and nephron-speciﬁc mRNA can be detected in the urine.
We wished to evaluate if nephron-speciﬁc mRNA could be
detected in patients after endovascular procedures as a new,
speciﬁc marker for CIKI.
Methods: Adults undergoing endovascular proce-
dures requiring contrast were consented. Urine was
collected over 24hrs. Urinalysis and mRNA extraction fol-
lowed. rtPCR using nephron-speciﬁc (Nephrin, Podocin,
Aquaporin-2) and a non-speciﬁc (TBF-Beta) probes. Clin-
ical data was also collected.
Results: Avg contrast:116cc. Avg age:69. Signiﬁcant
increases were found only in Nephrin mRNA at 6hrs,
and returned to baseline (n ¼ 20; P ¼ .03 - see graph).
Hematuria preceded this at 3hrs (P < .02) after contrast
exposure. There was no increase in the serum Cr (it
decreased).
Conclusions: Consistent with our animal model,
Nephrin mRNA and blood are detectable in the urine
within hours after contrast exposure, regardless of serum
creatinine. Urine mRNA is a potentially sensitive marker
for CIN.
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Nothing to disclose; D. Slack: Nothing to disclose.Fig. Nephrin mRNA detected in urine (normalized to urine
creatinine) prior to contrast exposure (time 0) or up to 24 hours
after ﬁrst contrast dose.
Fig. HIF-1a inhibition suppresses experimental AAA. Male
C57BL/6J mice were treated with vehicle, 2-ME (50 mg/kg/
day) or digoxin (2 mg/kg/day) starting 1 days prior to PRE
infusion, for a total of 15 days. Serial aortic diameter measurements
were performed using transabdominal ultrasonography. A, Fold
changes in mRNA expression in HiF-1a and VEGF-A, Rory-t,
Glut-1, and NOX2 in aneurysmal aortae (PRE infusion) and
control aortae (PBS infusion) as compared to normal mouse
aortae. B, Aortic diameter change following PPE infusion and
treatment with vehicle alone, 2ME or digoxin (chemical and
pharmaceutical grade) in vehicle. Data presented as mean plus
standard derivation. Two-way ANOVA followed by Newman-
Keuls test, *P < .05 and **P < .01 compared to vehicle treatment.
n ¼ 5-8 mice in each group.PS192.
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Objectives: HIF-1a critically regulates angiogenesis,
a histopathological feature of AAA disease. This study eval-
uated whether 2-methyoxyestradiol (2-ME) or digoxin,
known HIF-1a inhibitors, modulate experimental AAAs.
Methods: AAAs were created in male C57BL/6J
mice via transient intra-aortic porcine pancreatic elastase
(PPE) infusion. Mice were treated with vehicle, 2-ME
(50 mg/kg/day) or digoxin (2 mg/kg/day) starting prior
to, or following, PPE infusion. Therapeutic efﬁcacy was
evaluated using serial aortic diameter ultrasound imaging
and histological analyses at sacriﬁce.
Results: mRNAs for HIF-1a and four genes regulated
by HIF-1a, were up-regulated in aneurysmal aortae. In
vehicle-treated mice, aortic diameters enlarged remarkably
and persistently beginning the third day following PPE
infusion. Pretreatment with either 2-ME, or digoxin,
signiﬁcantly attenuated subsequent PPE-induced aortic
expansion (Fig). Initiated 4 days following PPE infusion,
treatment with both drugs also prevented further enlarge-
ment of existing AAAs. Histologically, treatment with 2-
ME or digoxin was associated with preserved medial
smooth muscle cellularity and elastic ﬁbers, and reduced
mural leukocyte inﬁltration and angiogenesis.
Conclusions: Pharmacological inhibition of HIF-1a
suppresses formation and progression of PPE-induced
AAAs, suggesting the translational potential for HIF-1a
inhibition in human AAA therapy.
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Objectives: Aortic mural angiogenesis is a key patho-
logic feature of AAA disease. We previously reported that
VEGF-receptor 2 expression correlated with experimental
AAA progression. This study evaluated the inﬂuence of
anti-VEGF-A monoclonal antibody (mAb) therapy on
AAA formation and progression in the porcine pancreatic
elastase (PPE) infusion model in C57Bl/6J mice.
Methods: PPE-infused mice were given anti-VEGF-A
neutralizing mAb or control mAb. Aortic aneurysm
progression was evaluated via serial transabdominal in
vivo ultrasonography and histology at sacriﬁce.
Results: In control mAb-treated mice, persistent and
signiﬁcant aortic enlargement was noted beginning the
third day following PPE infusion. Anti-VEGF-A mAbFig. A and B, Mice were injected with anti-VEGF-A or control
mAb (5 mg/kg/i.p. q.o.d) beginning 3 days prior to PRE infusion
(progression, A) or 5 days following PRE infusion (regression, B).
Diameters were measured via ultrasonography. C, Aortic frozen
sections stained for medial elastin (EVG), smooth muscles (SMC
a actin), angiogenesis (CD31), and leukocytes (CD11b for
monocytes/macrophages, CD3 for T cells and B220 for B cells).
Data presented as mean +/ S.D., n¼ 5-8 per group. ACS¼ aortic
cross section. *P < .05 and **P < .01, two- or one-way ANOVA
followed by Newman-Keuls test compared to control mAb.treatment initiated 3 days prior to PPE infusion signiﬁ-
cantly attenuated PPE-induced aortic expansion. Histolog-
ically, the VEGA-A neutralization resulted in preserved
medial smooth muscles and elastin, and reduced mural
leukocyte inﬁltration and angiogenesis. Although anti-
VEGF-A mAb treatment initiated 5 days following PPE
infusion reduced mural inﬂammation, aortic diameters
continued to enlarge.
Conclusions: Anti-VEGF-A mAb prevents the initia-
tion and subsequent progression of experimental AAAs.
The mAb treatment has limited effects on existing
aneurysms.
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Objectives: Unexplained aneurysm growth despite
multimodality imaging following EVAR is often attributed
to endotension. We tested a hypothesis that endotension
may be from a type 1a endoleak (EL) pressurizing the
aneurysm sac without net forward ﬂow, not visualized on
standard angiographic imaging.
Methods: A patient-speciﬁc aortic aneurysm phantom
was constructed of polyvinyl alcohol using 3D molding
techniques. A bifurcated stent graft was implanted and
the phantom connected to a hemodynamic simulator for
testing. Type 1a ELs were created using seven Fr catheters.
Three scenarios were studied: complete exclusion (no EL);
inﬂow with no sac outﬂow; and inﬂow with sac outﬂow.
DSA imaging was performed at 48kvP at 5fps followed
by delayed imaging (1 frame/min) over 30 minutes.
Results: With no EL, the systemic MAP (sMAP) aver-
aged 113 mmHg and Aneurysm Sac MAP (asMAP) aver-
aged 101 mmHg. (Table) With EL without outﬂow, the
sMAP averaged 116 mmHg and asMAP averaged 120
mmHg. EL ﬂow was bidirectional with no net forward
ﬂow. With EL with aneurysm sac outﬂow, the sMAP
averaged 119 mmHg and asMAP averaged 105.5 mmHg.
EL ﬂow was 39 cc/min across the EL channel. With DSA
imaging, the EL with no outﬂow was noted after >9 min
of delayed imaging.
Conclusions: Our model demonstrated a Type Ia EL
in the absence of aneurysm sac outﬂow resulting in full
pressurization of the aneurysm sac with biphasic (zero
net) ﬂow. This EL was not visible on standard contrast
DSA until >9 min. This model may serve as a ﬁrst step
in explaining both the mystery of endotension and in
vivo aneurysm sac growth with no detectable ELs using
current standard imaging modalities.
